Figure 3.
Plots illustrating total plasma β-amyloid levels of individual patients by time and dose level. (A) β-amyloid (18–35) Aβ18–35. (B) Aβ28–42. GSK: GSK933776. Patients = 6 for each dose group.
Plots illustrating total plasma β-amyloid levels of individual patients by time and dose level. (A) β-amyloid (18–35) Aβ18–35. (B) Aβ28–42. GSK: GSK933776. Patients = 6 for each dose group.